Log in
Enquire now
‌

US Patent 10071988 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Date Filed
February 9, 2017
Date of Patent
September 11, 2018
Patent Application Number
15428710
Patent Citations Received
‌
US Patent 11447503 Pyridine carbamates and their use as GLUN2B receptor modulators
‌
US Patent RE49517 Pyrazoles
0
‌
US Patent 11759455 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
‌
US Patent 11459336 Pyrazine carbamates and their use as GluN2B receptor modulators
‌
US Patent 10233173 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
‌
US Patent 10323021 Triazoles as NR2B receptor inhibitors
‌
US Patent 10377753 Substituted 4-azaindoles and their use as GluN2B receptor modulators
‌
US Patent 11530210 Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators
‌
US Patent 10617676 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulators
‌
US Patent 10766880 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10071988
Patent Primary Examiner
‌
Alicia L Otton

Find more entities like US Patent 10071988 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.